Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Osteoarthritis Treatment Market is segmented by drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic acid Injection, and other drugs), anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and other anatomies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Osteoarthritis Treatment Market Size

Osteoarthritis Treatment Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 7.68 Billion
Market Size (2030) USD 9.68 Billion
CAGR (2025 - 2030) 4.74 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Osteoarthritis Treatment Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Osteoarthritis Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Osteoarthritis Treatment Market Analysis

The Osteoarthritis Treatment Market size is estimated at USD 7.68 billion in 2025, and is expected to reach USD 9.68 billion by 2030, at a CAGR of 4.74% during the forecast period (2025-2030).

The COVID-19 pandemic had a short-term impact on the Osteoarthritis treatment market growth as it led to the cancelation or postponement of scheduled treatment procedures and a decrease in the number of new diagnoses of Osteoarthritis. According to an article published by PubMed Central in June 2022, there was a significant reduction in the healthcare of orthopedic and trauma patients during the COVID-19 pandemic in the Czech Republic. It also emphasized the healthcare system's shortcomings, including outpatient and inpatient care. Also, COVID-19 impacted pharmaceutical companies' research and development activities, along with delays in clinical trials of several new therapies worldwide, including treatments for Osteoarthritis drugs. Hence, the COVID-19 pandemic had a significant impact on the market initially. However, as the number of cases of COVID-19 has declined, the studied market has started to regain traction. It is expected to have healthy growth during the forecast period of the study.

The increasing geriatric population, increasing research & development activities, and funding for Osteoarthritis therapeutics are significant factors driving the growth of the studied market.

As the older population is more susceptible to Osteoarthritis, the increase in the global geriatric population is expected to have a significant impact on the studied market. For instance, according to the data published by the UN in 2022, the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. The source also claims that by 2050, the number of people aged 65 years or over worldwide is projected to be more than twice the number of children under age five and about the same as the number of children under age 12. Furthermore, according to an article published by PubMed Central in September 2022, Osteoarthritis is a significant cause of disability. It is the most common form of arthritis, affecting almost 10% of the global population aged 60 years and above. Hence, the rising geriatric population and the association of old age with Osteoarthritis will enhance the Osteoarthritis market growth during the forecast period.

Also, the increasing awareness among people, the availability of better treatment options such as Physical therapy and Pain management, and the willingness to take up treatment are expected to complement the growth of the Osteoarthritis treatment market. For instance, according to the Osteoarthritis (OA) Action Alliance, May is arthritis awareness month. It also stated that Osteoarthritis (OA) is the most common form of arthritis.

Additionally, the market players have been adopting various strategies, such as product launches, developments, acquisitions, and mergers, and collaborations, expanding their product portfolio in the studied market, and boosting the Osteoarthritis drugs market. For instance, in September 2021, Indian drug manufacturer Lupin Limited launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and Osteoarthritis in the US.

Therefore, owing to factors such as the increasing geriatric population, increasing awareness about Osteoarthritis, and product launches, the Arthritis therapeutics market is anticipated to witness growth over the analysis period. However, the high cost associated with hyaluronic acid products and other treatment procedures for Osteoarthritis treatment, such as Viscosupplementation, and the side effects related to the available therapies may impede the growth of the Osteoarthritis treatment market over the forecast period.

Osteoarthritis Treatment Industry Overview

The Osteoarthritis therapeutics market is slightly competitive, with several global players actively involved in developing new and advanced therapies for the treatment of Osteoarthritis or involved in acquisitions or collaboration agreements to make advancements in the studied market. Some key players in the studied market comprise Sanofi SA, Pfizer Inc., GlaxoSmithKline plc, Zimmer Biomet, Abbott Laboratories, Bayer AG, and Anika Therapeutics, among others.

Osteoarthritis Treatment Market Leaders

  1. Sanofi SA

  2. GlaxoSmithKline plc

  3. Pfizer Inc

  4. Bayer AG

  5. Zimmer Biomet

  6. *Disclaimer: Major Players sorted in no particular order
Osteoarthritis Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Osteoarthritis Treatment Market News

  • September 2022- Alkem Laboratories received regulatory approval for its off-the-shelf cell therapy product, StemOne, from the Drug Controller General of India (DCGI) for its launch in India. Alkem Laboratories, in collaboration with Stempeutics, launched the product for treating knee osteoarthritis, a degenerative joint disease.
  • August 2022- Shionogi & Co., Ltd., and Grünenthal GmbH entered a licensing agreement to commercialize injectable resiniferatoxin, a pipeline product of Grünenthal, in Japan. It is for the treatment of pain in patients with osteoarthritis of the knee.

Osteoarthritis Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Increasing Research & Development Activities and Funding for Osteoarthritis Therapeutics
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Treatment Procedures
    • 4.3.2 Side Effects Associated with the Available Therapeutics
  • 4.4 Porter' s Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Drugs
    • 5.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • 5.1.2 Corticosteroids
    • 5.1.3 Hyaluronic Acid Injection
    • 5.1.4 Other Drugs
  • 5.2 By Anatomy
    • 5.2.1 Ankle Osteoarthritis
    • 5.2.2 Hip Osteoarthritis
    • 5.2.3 Knee Osteoarthritis
    • 5.2.4 Shoulder Osteoarthritis
    • 5.2.5 Other Anatomies
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 OrthogenRx
    • 6.1.3 Abbott Laboratories
    • 6.1.4 Glaxosmithkline plc
    • 6.1.5 Sanofi SA
    • 6.1.6 Pfizer Inc.
    • 6.1.7 Zimmer Biomet
    • 6.1.8 Anika Therapeutics Inc.
    • 6.1.9 Viatris
    • 6.1.10 Novartis AG
    • 6.1.11 SEIKAGAKU CORPORATION
    • 6.1.12 Assertio Holdings Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Osteoarthritis Treatment Industry Segmentation

As per the scope of the report, osteoarthritis, also known as degenerative arthritis, is the most commonly occurring chronic condition that affects the joints. It leads to severe joint pain and stiffness of the affected body parts. Several treatments can cure osteoarthritis, including exercise to reduce joint pain and pain medications. The Osteoarthritis Treatment Market is segmented by drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic acid Injection, and other drugs), anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and other anatomies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value in (USD million) for the above segments.

By Drugs Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Hyaluronic Acid Injection
Other Drugs
By Anatomy Ankle Osteoarthritis
Hip Osteoarthritis
Knee Osteoarthritis
Shoulder Osteoarthritis
Other Anatomies
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Osteoarthritis Treatment Market Research FAQs

How big is the Osteoarthritis Treatment Market?

The Osteoarthritis Treatment Market size is expected to reach USD 7.68 billion in 2025 and grow at a CAGR of 4.74% to reach USD 9.68 billion by 2030.

What is the current Osteoarthritis Treatment Market size?

In 2025, the Osteoarthritis Treatment Market size is expected to reach USD 7.68 billion.

Who are the key players in Osteoarthritis Treatment Market?

Sanofi SA, GlaxoSmithKline plc, Pfizer Inc, Bayer AG and Zimmer Biomet are the major companies operating in the Osteoarthritis Treatment Market.

Which is the fastest growing region in Osteoarthritis Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Osteoarthritis Treatment Market?

In 2025, the North America accounts for the largest market share in Osteoarthritis Treatment Market.

What years does this Osteoarthritis Treatment Market cover, and what was the market size in 2024?

In 2024, the Osteoarthritis Treatment Market size was estimated at USD 7.32 billion. The report covers the Osteoarthritis Treatment Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Osteoarthritis Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Osteoarthritis Treatment Industry Report

The Osteoarthritis Treatment Market is segmented by drugs, anatomy, and geography. This industry report provides a comprehensive market overview, detailing the market trends and industry outlook. The analysis includes insights into the market size and market share, along with a historical overview and market forecast. The industry analysis highlights the market growth and identifies the market leaders within the osteoarthritis treatment sector.

The report delves into various drug categories such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, and Hyaluronic acid Injection. It also covers different anatomical segments including Ankle, Hip, Knee, and Shoulder Osteoarthritis. The geographical segmentation spans North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

This industry research provides valuable market data and industry statistics, offering a detailed market review and market predictions. The market segmentation and market value are thoroughly examined, providing a clear understanding of the industry size and industry trends.

The report example and report PDF are available for download, providing a comprehensive industry outlook and market forecast. This market research is crucial for understanding the market growth and the role of market leaders in driving the industry forward. The research companies involved in this study offer extensive insights into the market, making this a valuable resource for industry sales and market analysis.